FBTIX : FIDELITY ADV BIOTECHNOLOGY I

 
2
 
 
 

ZACKS RANK: 2 - BUY

Ticker: FBTIX
Manager: Rajiv Kaul
Manager Since: 10/05
NAV (04/18/2014): 18.95
Objective: Equity - Sector Health
Peer: HL MG
Net Assets ($mil): 442.44
Inception: 12/27/2000
FBTIX : Description

Fidelity Advisor Biotechnology Fund, Class I was incepted in December 2000 and is managed by the Fidelity Group. The objective of the fund is to seek capital appreciation. The fund normally invests primarily in common stocks. The fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund offers dividends and capital gains twice a year in September and December.

FBTIX : Composition - 04/14
Stocks 99.11%
Foreign Stocks 0.34%
Cash 3.84%
Bonds 0.00%
Foreign Bonds 0.00%
Preferred 0.00%
Convertible 0.07%
Other -3.03%
Foreign Hedged 0.00%
Composition Horizontal Bar Chart
FBTIX : Style Analysis - 04/14
Large Growth 18.99%
Large Value 0.00%
Small Growth 0.00%
Small Value 0.00%
Foreign Stock 18.99%
Emerging Market 0.00%
Precious Metals 0.00%
Intermediate Bond 0.00%
High Yield Bond 0.00%
Foreign Bond 35.27%
Style Analysis Horizontal Bar Chart
FBTIX : Risk Analysis
Beta v. S&P 500 1.02
Beta v. EAFE 0.01
Beta v. Barclays Agg Bond 1.77
Alpha 3 Yr 23.48
Alpha 5 Yr 11.49
R-Sq 3 Yr 0.31
R-Sq 5 Yr 0.31
Std Dev 3 Yr 20.82
Std Dev 5 Yr 20.91
Sharpe 3 Yr 1.96
Sharpe 5 Yr 1.51
FBTIX : Fees
Expense Ratio 0.85
% Max Load NA
% Min Load NA
% Deferred Load NA
% Redemption 0.75
% Max 12 B1 Fee 0.00
% Max Mgt Fee 0.55
FBTIX : Purchase Choices:
Min Initial Investment 2500
Min Subsequent Investment 0
FBTIX : Returns Analysis - Annual

Line chart

  2004200520062007200820092010201120122013YTD
NAV ($) 6.707.237.497.186.347.007.789.2412.0219.6718.95
Total Return (%) 12.227.913.592.75-11.6910.4111.1418.7637.4664.095.64
Annual Dividend Yield (%) 0.000.000.000.000.000.000.000.000.000.000.00
Relative Performance
Rel Performance-S&P500(%) 13.5430.20-122.00-27.45253.09-160.10-39.21166.67214.71317.1538.43
Rel Performance-Obj.Ret.(%) 34.47-10.52-1.39-61.15119.98-114.6631.18110.18182.32177.89-11.72
Ret.Quintile vs Obj(1 is best) 24351521114
Turnover, Yields, and Gains
Fund Assets Net($mil) 1111123639318442
Annual Turnover (%) 50.0044.0062.00120.00132.0073.00115.0099.0082.0022.000.00
Annual Dividend Paid ($) 0.000.000.000.000.000.000.000.000.000.000.00
Annual Capital Gains Paid($) 0.000.000.000.530.000.000.000.000.680.050.00
FBTIX : Returns Analysis - Trailing Total Return
  1 Month 3 Month 6 Month YTD 1 Year 3 Year 5 Year 10 Year 15 Year 20 Year
Total Return (through 04/14) -12.21% 5.64% 9.44% 5.64% 44.61% 38.15% 29.06% 13.64% NA NA
Ret. Percentile vs. Obj. (1 is best) 94 68 93 68 19 2 14 11 NA NA
FBTIX : Stock Portfolio Snapshot - 04/14
Average Price/Earnings 41.60
Average Price/Book 5.73
Average EPS Growth 15.50
Average Market Value 45,912.00
FBTIX : Stock Sector Breakout - 04/14
Stock Sector Breakout
FBTIX : Top Holdings - 04/14
Name Weight Shares
GILEAD SCIENCES INC 17.28 2,337,276
AMGEN INC 13.39 1,108,745
BIOGEN IDEC INC 8.06 316,856
CELGENE CORP 7.47 483,168
AEGERION PHARMACEUTICALS INC 2.44 282,543
REGENERON PHARMACEUTICALS 4.59 153,164
VERTEX PHARMACEUTICALS INC 3.38 455,330
PHARMACYCLICS INC 2.49 201,133
ALEXION PHARMACEUTICALS INC 4.97 387,944